Zoetis Inc. (ZTS) NYSE

Currency In USD

AD

Zoetis Inc.

Address

10 Sylvan Way

Parsippany, NJ 07054

United States of America (the)

Phone

973 822 7000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

14500

First IPO Date

February 01, 2013

Key Executives

NameTitlePayYear Born
Wetteny N. JosephSpecial Advisor to the CEO1.8M1972
Kristin C. PeckChief Executive Officer & Director5.42M1971
Roxanne LaganoExecutive Vice President, General Counsel & Corporate Secretary1.44M1965
Robert J. PolzerScientific Advisor1.45M1969
Jamie BrannanExecutive Vice President & Chief Commercial Officer1.74M1973
James K. SaccaroExecutive VP, CFO & COO01973
Abhay U. NayakExecutive VP & President of U.S. Commercial Operations01988
Julie A. FullerExecutive Vice President, Chief Human Resources Officer & Global Operations01973
Keith SarbaughExecutive Vice President & Chief Digital and Technology Officer01979
Nick AshtonExecutive Vice President and President of Global Manufacturing & Supply01974
Steven FrankVice President of Investor Relations0N/A
Jeannette Ferran AstorgaExecutive Vice President of Corporate Affairs & Chief Sustainability Officer01976
AD

Description

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

AD